Post-cardiac arrest brain injury now hinges on disciplined physiologic control
Post-cardiac arrest brain injury remains the dominant driver of death and severe disability among comatose survivors after successful resuscitation. The clinical framework synthesized in this review places cerebral protection ahead of reflexive escalation, and it does so with unusual specificity: oxygenation, ventilation, perfusion, temperature control, seizure surveillance, and delayed prognostication are treated as linked steps rather than isolated tasks.
The practical message is straightforward. Early management should preserve the brain’s narrow physiologic tolerance while avoiding interventions that can distort the neurologic examination or trigger premature decisions about futility. In this setting, the difference between a recoverable and an irreversible injury often depends on whether clinicians keep gas exchange, blood pressure, and temperature within a narrow range during the first critical days after return of spontaneous circulation.
Oxygen, carbon dioxide, and perfusion form the first line of cerebral protection
The review aligns current practice around peripheral oxygen saturation targets between 94% and 98%, with avoidance of both hypoxemia and unnecessary hyperoxia. In a brain already exposed to global ischemia-reperfusion injury, excess oxygen can intensify oxidative stress, while low oxygen delivery compounds metabolic failure in the most vulnerable cortical and subcortical regions. The target range is not arbitrary; it reflects an attempt to preserve tissue oxygen delivery without feeding the biochemical cascades that can worsen secondary injury.
Ventilation is just as tightly bounded. Recommended normocapnia with a partial pressure of carbon dioxide between 35 and 45 mm of mercury aims to avoid the cerebral vasoconstriction of hypocapnia and the edema-promoting vasodilation of hypercapnia. For a post-arrest patient, swings in carbon dioxide can quickly alter cerebral blood flow, making a seemingly minor ventilator adjustment clinically meaningful.
Perfusion is handled with similar caution. Individualized targeting of mean arterial pressure at 60 to 65 mm of mercury reflects the reality that injured brains may not autoregulate normally, and systemic hypotension can further reduce cerebral blood flow at the very moment when reperfusion reserve is already exhausted. A one-size-fits-all hemodynamic goal is unlikely to serve every patient equally, which is why the review frames perfusion support as individualized rather than purely protocol driven.
Fever prevention has replaced routine hypothermia as the central temperature strategy
Active fever prevention occupies a central role in the framework. Core temperature should be maintained at or below 37.5 degrees Celsius for 36 to 72 hours, and routine hypothermia is not recommended. In biologic terms, fever increases cerebral metabolic demand precisely when supply-demand mismatch is most dangerous. Suppressing fever is therefore a way to reduce secondary injury without imposing the additional hemodynamic and metabolic burden that deeper cooling can bring.
This is an important pivot in practice. A measured fever-prevention strategy is easier to standardize, easier to monitor, and less likely to interfere with bedside assessment than older, more aggressive cooling pathways. The review places temperature management in a narrower but more usable space: prevent hyperthermia reliably, but do not assume that deeper hypothermia is automatically neuroprotective.
Continuous EEG turns seizure detection into a treatment pathway
Continuous electroencephalography monitoring is presented as a core neurologic tool rather than an optional add-on. Seizures after cardiac arrest may be clinically silent, especially when patients remain sedated or mechanically ventilated, yet their presence can signal ongoing cortical stress and worsen injury if untreated. The framework supports seizure treatment when detected, but not routine prophylactic antiseizure therapy.
That distinction matters at the bedside. Prophylactic drug exposure can cloud the exam and introduce adverse effects without clear evidence of universal benefit, while EEG-guided treatment targets the subgroup with demonstrable electrical instability. The result is a more selective and physiologically grounded approach: detect abnormal cortical activity, treat it when present, and avoid medication use that could obscure the very signals needed for recovery tracking.
Short-acting sedation is favored because it allows neurological assessment without forcing a prolonged diagnostic blackout. Sedation choices in this population are never neutral; even modest pharmacologic carryover can delay recognition of awakening, confound motor responses, and make prognostication less reliable. A regimen that can be tapered and reassessed with minimal residue is therefore more than a convenience. It is part of the diagnostic process itself.
Prognostication should wait until multiple domains agree
The review repeatedly returns to one caution: prognostication should not be rushed. Multimodal neurologic prediction should be performed at least 72 hours after return of spontaneous circulation, and decisions should rely on concordant predictors across several domains rather than a single ominous finding. This is a deliberate safeguard against the self-fulfilling nature of early pessimism.
After cardiac arrest, the neurologic examination can be distorted by sedation, metabolic derangement, residual paralysis, and evolving systemic illness. A poor early motor response or abnormal brain imaging finding may be real, but isolated signals can mislead if they are interpreted before confounders have cleared. By requiring agreement across modalities, the framework tries to reduce the risk that one incomplete data point becomes the basis for withdrawal of life-sustaining therapy.
In practical terms, this means prognostic judgments should be built slowly, with careful attention to timing and internal consistency. A brain that is still recovering from ischemia-reperfusion injury can look far worse in the first 48 hours than it will after physiologic stabilization. Waiting for that trajectory to declare itself is not indecision; it is part of accurate neurologic medicine.
What this framework changes for intensivists and neurologists
The strongest contribution of this review is not a single device, drug, or biomarker. It is the insistence that post-cardiac arrest syndrome must be managed as a dynamic neurocritical illness in which oxygen delivery, ventilation, blood pressure, temperature, and electrographic stability all influence the eventual neurologic outcome.
At the bedside, this translates into a sequence of disciplined moves: maintain oxygenation in range, keep carbon dioxide normal, support perfusion without overcorrecting, suppress fever, watch for seizures with continuous EEG, limit sedative carryover, and delay final prognostication until the picture is complete. Each step is simple in isolation. The challenge is executing them together without drift, overreaction, or premature closure.
The review does not claim that any one maneuver guarantees recovery. It argues instead for a tightly coordinated strategy that protects the brain during its most fragile period and resists the temptation to interpret incomplete information too early. In a syndrome where secondary injury determines so much of the outcome, that restraint may be the most consequential intervention of all.